Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Film Coated Tablets 28 X 30 mg |
|
45478 | |
|
Film Coated Tablets 28 X 60 mg |
|
45479 | |
|
Film Coated Tablets 28 X 90 mg |
|
45480 |
Related information
Dosage
Hyperparathyroidism: The usual starting dosage is 30 mg (one tablet) once per day.
For parathyroid cancer or primary hyperparathyroidism: The usual starting dosage is 30 mg (one tablet) twice per day.
Should be taken with food.
Indications
Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy.
Cinacalcet Taro may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate.
Reduction of hypercalcaemia in patients with parathyroid carcinoma.
Reduction of hypercalcaemia in patients with:
Parathyroid carcinoma.
Primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.
Contra-Indications
Hypersensitivity to the active ingredient or to any of the other ingredients included in this medicine.
Special Precautions
Please refer to the license holder for further details.
